Turkish Abstract Abstract Free Full Text English Similar Articles Mail to Author

¹MD, University of Health Sciences, Ankara Ulucanlar Eye Education and Research Hospital, Ankara, Türkiye
²MD, Proffesor, University of Health Sciences, Ankara Ulucanlar Eye Education and Research Hospital, Ankara, Türkiye DOI : 10.37845/ret.vit.2023.32.24 In the COVID-19 pandemic, which causes high mortality and morbidity, promising developments are achieved as a result of the global vaccination campaign. However, there is an increase in reported side effects with widespread vaccination. In this report, we present a 44-year-old female patient who presented with unilateral central serous chorioretinopathy (CSCR) three days after the first injection of the BNT162b2 COVID-19 vaccine. Although the possibility of coincidence cannot be excluded, our case provides support for the few cases of CSCR after COVID-19 vaccination in the literature. Keywords : BNT162b2, central serous chorioretinopathy, COVID-19, mRNA vaccine